Economic Evaluation of Voriconazole versus Caspofungin for the Treatment of Invasive Aspergillosis in Spain

Alfonso Domínguez-Gil; Isabel Martín; Mercedes García Vargas; Almudena Del Castillo; Silvia Díaz; Cristina Sánchez


Clin Drug Invest. 2007;27(3):197-205. 

In This Article


Using the usual costs and patterns of treatment of invasive mycosis in Spain, voriconazole was found to be more cost effective than caspofungin for the treatment of invasive aspergillosis in patients with a bodyweight <103.42kg.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.